Skip Navigation

Each Transplant Center listing contains a Survival by Patient's Age, Disease Type and Stage section, which provides survival outcomes by the following 26 broad disease categories. Click the category name to see the list of specific diseases that belong to the category.

  1. Acute myelogenous leukemia in first complete remission 
  2. Acute myelogenous leukemia in second complete remission
  3. Acute myelogenous leukemia in third or higher complete remission, relapse, or primary induction failure 
  4. Acute lymphoblastic leukemia in first complete remission 
  5. Acute lymphoblastic leukemia in second complete remission 
  6. Acute lymphoblastic leukemia in third or higher complete remission, relapse, or primary induction failure 
  7. Chronic myelogenous leukemia in first chronic phase 
  8. Chronic myelogenous leukemia in accelerated phase or second chronic phase 
  9. Chronic myelogenous leukemia in blastic phase 
  10. Chronic lymphocytic leukemia 
  11. Other leukemia 
  12. Myelodysplastic disorders - Refractory anemia, Refractory anemia with ringed sideroblast, Refractory cytopenia with multilineage dysplasia, Refractory cytopenia with multilineage dysplasia and ringed sideroblast 
  13. Myelodysplastic disorders - Refractory Anemia with excess blasts (with 5-9% brasts (RAEB-1) and 10-19% blasts (RAEB-2)) 
  14. Myelodysplastic disorders - Other MDS 
  15. Myeloproliferative syndromes 
  16. Non-Hodgkin lymphoma 
  17. Hodgkin lymphoma
  18. Multiple myeloma / Plasma cell disorder
  19. Solid tumors / Other malignancies 
  20. Severe aplastic anemia 
  21. Inherited abnormalities of erythrocyte differentiation or function 
  22. Disorders of the immune system 
  23. Inherited disorders of metabolism 
  24. Histiocytic disorders 
  25. Inherited abnormalities of platelets 
  26. Auto immune diseases and other non-malignant diseases

1-3: Acute myelogenous leukemia (AML or ANLL) 

  • AML with t(8;21) (q22;q22) (AML1 / ETO)
  • AML with abnormal bone marrow eosinophils and inv(16)(p13;q22) or t(16;16) (p13;q22), (CBFß /MYH11)
  • APL with t(15;17)(q22;q12),(PML/RARa) and variant (M3)
  • AML with 11q23 (MLL) abnormalities (i.e., t(4;11),t(6;11), t(9;11), t(11;19))
  • AML with multi-lineage dysplasia
  • AML, minimally differentiated (M0)
  • AML without maturation (M1)
  • AML with maturation (M2)
  • Acute myelomonocytic leukemia (M4)
  • Acute monoblastic / acute monocytic leukemia (M5)
  • Acute erythroid leukemia (erythroid / myeloid and pure erythroleukemia) (M6)
  • Acute megakaryoblastic leukemia (M7)
  • Acute basophilic leukemia
  • Acute panmyelosis with myelofibrosis
  • Myeloid sarcoma
  • Granulocytic sarcoma
  • AML or ANLL, not otherwise specified

4-6: Acute lymphoblastic leukemia (ALL) 

  • Precursor B-cell ALL
  • t(9;22)(a34;q11); BCR / ABL+
  • t(v;11q23); MLL rearranged
  • t(1;19)(q23;p13) E2A / PBX1
  • t(12;21)(p12;22) ETV / CBFa
  • ALL T-lineage / precursor T-cell ALL
  • Mature B-cell (L3)
  • T-cell
  • Precursor T-lymphoblastic lymphoma / leukemia
  • ALL, not otherwise specified

7-9: Chronic myelogenous leukemia (CML) 

  • Ph1+; BCR/ABL+
  • Ph1+; BCR/ABL–
  • Ph1+; BCR/ABL unknown
  • Ph1–; BCR/ABL+
  • Ph1 unknown; BCR/ABL+

10. Chronic lymphocytic leukemia (CLL)

  • CLL, B-cell / small lymphocytic lymphoma
  • CLL, T-cell
  • CLL, not otherwise specified


11. Other leukemia 

  • Acute undifferentiated leukemia
  • Biphenotypic, bilineage or hybrid leukemia
  • Acute mast cell leukemia
  • Hairy cell leukemia
  • Prolymphocytic leukemia (PLL), B-cell
  • PLL, T-cell
  • PLL, not otherwise specified
  • Atypical CML: Ph1–; BCR/ABL–
  • Atypical CML: Ph1–; BCR/ABL unknown
  • Atypical CML: Ph1 unknown; BCR/ABL–
  • Atypical CML: Ph1 unknown; BCR/ABL unknown
  • Other leukemia, not otherwise specified

12. Myelodysplastic disorders - Refractory anemia, Refractory anemia with ringed sideroblast, Refractory cytopenia with multilineage dysplasia, Refractory cytopenia with multilineage dysplasia and ringed sideroblast 

  • Refractory anemia
  • Refractory anemia with ringed sideroblast
  • Refractory cytopenia with multilineage dysplasia
  • Refractory cytopenia with multilineage dysplasia and ringed sideroblast

13. Myelodysplastic disorders - Refractory Anemia with excess blasts (with 5-9% brasts (RAEB-1) and 10-19% blasts (RAEB-2) 

  • Refractory Anemia with excess blasts (with 5-9% blasts (RAEB-1))
  • Refractory Anemia with excess blasts (with 10-19% blasts (RAEB-2))
  • Refractory anemia with excess blasts (RAEB)
  • Refractory anemia with excess blasts in transformation (RAEB-T)

14. Myelodysplastic disorders - Other MDS 

  • 5q– syndrome
  • Chronic myelomonocytic leukemia (CMML)
  • MDS unclassifiable, not otherwise specified

15. Myeloproliferative syndromes (MPS) 

  • Chronic neutrophilic leukemia
  • Chronic eosinophilic leukemia (hypereosinophilic syndrome)
  • Polycythemia vera
  • Chronic idiopathic myelofibrosis (with extra-medullary hematopoiesis), myelofibrosis with myeloid metaplasia, acute myelofibrosis or myelosclerosis
  • Essential thrombocythemia
  • Chronic MPS disorder, not otherwise specified

16. Non-Hodgkin lymphoma 

  • Lymphoplasmacytic lymphoma
  • Splenic marginal zone B-cell lymphoma
  • Extranodal marginal zone B-cell lymphoma of mucosal associated lymphoid tissue type
  • Nodal marginal zone B-cell lymphoma (± monocytoid B-cells)
  • Follicular, predominantly small cleaved cell (Grade I follicle center lymphoma)
  • Follicular, mixed, small cleaved and large cell (Grade II follicle center lymphoma)
  • Follicular, predominantly large cell (Grade III follicle center lymphoma)
  • Follicular (grade unknown)
  • Mantle cell lymphoma
  • Diffuse, large B-cell lymphoma, including primary mediastinal (thymic) large B-cell lymphoma (large B-cell subtype)
  • Burkitt lymphoma / Burkitt cell leukemia
  • High grade B-cell lymphoma, Burkitt-like (provisional entity)
  • Primary CNS lymphoma
  • Other B-cell lymphoma
  • Extranodal NK / T-cell lymphoma, nasal type
  • Enteropathy-type T-cell lymphoma
  • Hepatosplenic gamma-delta T-cell lymphoma
  • Subcutaneous panniculitis-like T-cell lymphoma
  • Mycosis fungoides
  • Sezary syndrome
  • Anaplastic large-cell lymphoma, T / null cell, primary cutaneous type
  • Peripheral T-cell lymphoma, not otherwise specified
  • Angioimmunoblastic T-cell lymphoma
  • Anaplastic large-cell lymphoma, T / null cell, primary systemic type
  • Other T-cell / NK-cell lymphoma
  • Large T-cell granular lymphocytic leukemia
  • Aggressive NK-cell leukemia
  • Adult T-cell lymphoma / leukemia (HTLV1 associated)
  • Waldenstrom macroglobulinemia
  • Diffuse, small cleaved cell (Follicular center lymphoma, diffuse)
  • Diffuse, mixed, small and large cell
  • Diffuse, large cell
  • Large cell, immunoblastic (B-cell only)
  • Small noncleaved cell, unclassified
  • Mycosis fungoides
  • Other non-Hodgkin lymphoma


17. Hodgkin lymphoma 

  • Nodular lymphocyte predominant Hodgkin lymphoma
  • Lymphocyte-rich
  • Nodular sclerosis
  • Mixed cellularity
  • Lymphocyte depleted
  • Hodgkin lymphoma, not otherwise specified

18. Multiple myeloma / Plasma cell disorder

  • Multiple myeloma
  • Plasma cell leukemia
  • Solitary plasmacytoma (no evidence of myeloma)
  • Primary amyloidosis
  • Other plasma cell disorder, not otherwise specified

19. Solid tumors / Other malignancies 

  • Breast cancer, inflammatory
  • Breast cancer, not inflammatory
  • Breast cancer, not otherwise specified
  • Lung, small cell
  • Lung, non-small cell
  • Lung, not otherwise specified
  • Germ cell tumor, extragonadal
  • Testicular
  • Ovarian (epitheleal)
  • Bone sarcoma, excluding Ewing family tumors
  • Ewing family tumors of bone (includes PNET)
  • Ewing family tumors, extra-osseous (includes PNET)
  • Fibrosarcoma
  • Hemangiosarcoma
  • Leiomyosarcoma
  • Liposarcoma
  • Lymphangio sarcoma
  • Neurogenic sarcoma
  • Rhabdomyosarcoma
  • Synovial sarcoma
  • Soft tissue sarcoma (excluding Ewing family tumors)
  • Central nervous system tumor, including CNS PNET
  • Medulloblastoma
  • Neuroblastoma
  • Head / neck
  • Mediastinal neoplasm
  • Colorectal
  • Gastric
  • Pancreatic
  • Hepatobiliary
  • Prostate
  • External genitalia
  • Cervical
  • Uterine
  • Vaginal
  • Melanoma
  • Wilm tumor
  • Retinoblastoma
  • Thymoma
  • Solid tumor, not otherwise specified
  • Renal cell

20. Severe aplastic anemia

  • Acquired SAA secondary to hepatitis
  • Acquired SAA secondary to toxin/other drug
  • Acquired severe aplastic anemia, not otherwise specified
  • Acquired amegakaryocytosis (not congenital)
  • Acquired acquired pure red cell aplasia (not congenital)
  • Other acquired cytopenic syndrome
  • Paroxysmal nocturnal hemogloblinuria (PNH)

21. Inherited abnormalities of erythrocyte differentiation or function 

  • Shwachman-Diamond
  • Diamond-Blackfan anemia (pure red cell aplasia)
  • Other constitutional anemia
  • Fanconi anemia
  • Sickle thalassemia
  • Sickle cell disease
  • Thalassemia, not otherwise specified
  • Other hemoglobinopathy

22. Disorders of the immune system 

  • Adenosine deaminase (ADA) deficiency / severe combined immunodeficiency (SCID)
  • Absence of T and B cells SCID
  • Absence of T, normal B cell SCID
  • Omenn syndrome
  • Reticular dysgenesis
  • Bare lymphocyte syndrome
  • Other SCID
  • Ataxia telangiectasia
  • HIV infection
  • DiGeorge anomaly 
  • Common variable immunodeficiency
  • Leukocyte adhesion deficiencies, including GP180, CD-18, LFA and WBC adhesion deficiencies
  • Kostmann agranulocytosis (congenital neutropenia)
  • Neutrophil actin deficiency
  • Cartilage–hair hypoplasia
  • CD40 ligand deficiency
  • Other immunodeficiencies
  • Chediak-Higashi syndrome
  • Chronic granulomatous disease
  • Wiskott-Aldrich syndrome
  • X-linked lymphoproliferative syndrome

23. Inherited disorders of metabolism 

  • Osteopetrosis (malignant infantile osteopetrosis)
  • Metachromatic leukodystrophy (MLD)
  • Adrenoleukodystrophy (ALD)
  • Krabbe disease (Globoid leukodystrophy)
  • Lesch-Nyhan (HGPRT deficiency)
  • Neuronal ceroid lipofuscinosis (Batten disease)
  • Hurler syndrome (IH)
  • Scheie syndrome (IS)
  • Hunter syndrome (II)
  • Sanfilippo (III)
  • Morquio (IV)
  • Maroteaux-Lamy (VI)
  • ß-glucuronidase deficiency (VII)
  • Mucopolysaccharidosis (V)
  • Mucopolysaccharidosis, not otherwise specified
  • Gaucher disease
  • Niemann-Pick disease
  • I-cell disease
  • Wolman disease
  • Glucose storage disease
  • Mucolipidoses, not otherwise specified
  • Aspartyl glucosaminidase
  • Fucosidosis
  • Mannosidosis
  • Polysaccharide hydrolase abnormality, not otherwise specified
  • Other inherited metabolic disorder

24. Histiocytic disorders 

  • Familial erythro hemophagocytic lymphohistiocytosis (FELH)
  • Langerhans cell histiocytosis (histiocytosis-X)
  • Hemophagocytosis (reactive or viral associated)
  • Malignant histiocytosis
  • Other histiocytic disorder

25. Inherited abnormalities of platelets

  • Congenital amegakaryocytosis / congenital thrombocytopenia
  • Glanzmann thrombasthenia
  • Other inherited platelet abnormality

26. Auto immune diseases and other non-malignant diseases

  • Rheumatoid arthritis
  • Psoriatic arthritis / psoriasis
  • Juvenile idiopathic arthritis (JIA): systemic (Stills disease)
  • JIA: oligoarticular
  • JIA: polyarticular
  • JIA: other
  • Other arthritis
  • Multiple sclerosis
  • Systemic sclerosis (scleroderma)
  • Systemic lupus erythematosus (SLE)
  • Sjögren syndrome
  • Polymyositis / dermatomyositis
  • Antiphospholipid syndrome
  • Other connective tissue disease
  • Wegener granulomatosis
  • Classical polyarteritis nodosa
  • Microscopic polyarteritis nodosa
  • Churg-strauss
  • Giant cell arteritis
  • Takayasu syndrome 
  • Behcet syndrome
  • Overlap necrotizing arteritis
  • Other vasculitis
  • Myasthenia gravis
  • Other autoimmune neurological disorder
  • Idiopathic thrombocytopenic purpura (ITP)
  • Hemolytic anemia
  • Evan syndrome
  • Other autoimmune cytopenia
  • Crohn disease
  • Ulcerative colitis
  • Other autoimmune bowel disorder
  • Other non-malignant diseases